Primary ovarian mucinous cystadenocarcinomas

American Journal of Surgical Pathology

Volumn 22, Issue 12, 1998, Pages 1449-1462

  Hoerl, H Daniel ^b   Hart, William R ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

Borderline tumor; Cystadenocarcinoma; Microinvasion; Mucinous carcinoma; Ovarian neoplasm; Prognosis

Indexed keywords

ARTICLE; CANCER CLASSIFICATION; CANCER INVASION; CANCER RECURRENCE; CLINICAL FEATURE; CYSTADENOCARCINOMA; DISEASE COURSE; GRANULOMA; HISTOPATHOLOGY; OVARY CARCINOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CYSTADENOCARCINOMA, MUCINOUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROGNOSIS; STROMAL CELLS;

EID: 0031771728     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-199812000-00002     Document Type: Article

References (24)

1. Bell DA, Scully RE. Ovarian serous borderline tumors with stromal microinvasion: a report of 21 cases. Hum Pathol 1990;21:397-403.
2. Cariker M, Dockerty M. Mucinous cystadenomas and mucinous cystadenocarcinomas of the ovary. A clinical and pathological study of 335 cases. Cancer 1954;7:302-10.
3. Chaitin BA, Gershenson DM, Evans HL. Mucinous tumors of the ovary: a clinicopathologic study of 70 cases. Cancer 1985;55: 1958-62.
4. DeNictolis M, Motironi R, Tommasoni S, Valli M, Pisani E, Fabris G, Prat J. Benign, borderline, and well-differentiated malignant intestinal mucinous tumors of the ovary: a clinicopathologic, histochemical, immunohistochemical, and nuclear quantitative study of 57 cases. Int J Gynecol Pathol 1994;13:10-21.
5. Guerrieri C, Hogberg T, Wingren S, Fristedt S, Simonsen E, Boeryd B. Mucinous borderline and malignant tumors of the ovary. A clinicopathologic and DNA ploidy study of 92 cases. Cancer 1994;74:2329-40.
6. Hart WR. Ovarian epithelial tumors of borderline malignancy (carcinomas of low malignant potential). Hum Pathol 1977;8:541-9.
7. Hart WR. Pathology of malignant and borderline (low malignant potential) Epithelial Tumors of Ovary. In: Coppleson M, Monaghan JM, Morrow CP, Tattersall MHN, eds. Gynecologic Oncology, 2nd ed. Edinburgh: Churchill-Livingstone; 1992:863-87.
8. Hart WR, Norris HJ. Borderline and malignant mucinous tumors of the ovary. Histologic criteria and clinical behavior. Cancer 1973; 31:1031-45.
9. Kikkawa F, Kawai M, Tamakoshi K, et al. Mucinous carcinoma of the ovary: clinicopathologic analysis. Oncology 1996;53:303-7.
10. Lash RH, Hart WR. Intestinal adenocarcinomas metastatic to the ovaries: a clinicopathologic evaluation of 22 cases. Am J Surg Pathol 1987;11:114-21.
11. Nayar R, Siriaunkgul S, Robbins KM, McGowan L, Ginzan S, Silverberg SG. Microinvasion in low malignant potential tumors of the ovary. Hum Pathol 1996;27:521-7.
12. Pettersson F. Carcinoma of the ovary. In: Pettersson F, Creasman WT, Shepherd JH, Pecorelli S, eds. Annual Report on the Results of Treatment in Gynecological Cancer, vol. 22. Stockholm: International Federation of Gynecology and Obstetrics, 1993:38-43.
13. Prat J, Scully RE. Ovarian mucinous tumors with sarcoma-like mural nodules: a report of seven cases. Cancer 1979;44:1332-44.
14. Prat J, Young RH, Scully RE. Ovarian mucinous tumors with foci of anaplastic carcinoma. Cancer 1982;50:300-4.
15. Prayson RA, Hart WR, Petras RE. Pseudomyxoma peritonei: A clinicopathologic study of 19 cases with emphasis on site of origin and nature of associated ovarian tumors. Am J Surg Pathol 1994; 18:591-603.
16. Ronnett BM, Kurman RJ, Zahn CM, Shmookler BM, Jablonski KA, Kass ME, Sugarbaker PH. Pseudomyxoma peritonei in women: a clinicopathologic analysis of 30 cases with emphasis on site of origin, prognosis, and relationship to ovarian mucinous tumors of low malignant potential. Hum Pathol 1995;26:509-24.
17. Schueler JA, Cornelisse CJ, Hermans J, Trimbos JB, vanderBurg MEL, Fleuren GJ. Prognostic factors in well-differentiated early-stage epithelial ovarian cancer. Cancer 1993;71:787-95.
18. Schueler JA, Trimbos JB, Burg M, Cornelisse CJ, Hermans J, Fleuren GJ. DNA index reflects the biological behavior of ovarian carcinoma stage I-IIa. Gynecol Oncol 1996;62:59-66.
19. Siriaunkgul S, Robbins KM, McGowan L, Silverberg SG. Ovarian mucinous tumors of low malignant potential: a clinicopathologic study of 54 tumors of intestinal and mullerian type. Int J Gynecol Pathol 1995;14:198-208.
20. Sumithran E, Susil BJ, Looi LM. The prognostic significance of grading in borderline mucinous tumors of the ovary. Hum Pathol 1988;19:15-8.
21. Trimbos JB, Scheuler JA, vanderBurg M, Hermans J, vanLent M, Heintz APM, Fleuren GJ. Watch and wait after careful surgical treatment and staging in well-differentiated early ovarian cancer. Cancer 1991;67:597-602.
22. Watkin W, Silva EG, Gershenson DM. Mucinous carcinoma of the ovary: pathologic prognostic factors. Cancer 1992;69:208-12.
23. Young R, Gilks B, Scully R. Mucinous tumors of the appendix associated with mucinous tumors of the ovary and pseudomyxoma peritonei: a clinicopathologic analysis of 22 cases supporting an origin in the appendix. Am J Surg Pathol 1991;15:415-29.
24. Young RH, Hart WR. Metastases from carcinomas of the pancreas simulating primary mucinous tumors of the ovary: a report of seven cases. Am J Surg Pathol 1989;13:748-56.